The "Short" opinion expressed is on a mere technical, and medium term, factor.
JNJ is one of the top rating notch in USA with an AAA. In or view the company is really well managed with an interesting dividend yeld of 2.9%. In 2018 we still belive that earning per share could reach 7.00 dollars, and in 2019 8.00 dollars; the Vision Care and the Surgery business could lead this earnings improvement.
Total debt: 32.5 bill. Annual net profit: 16.6 bill.
IMPORTANT:
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
Always make your analysis of your own before your trade.
If you find useful my analysis, please hit the LIKE button and follow me.
Please remind yourself that this is just my personal view on the market. My analysis should NOT serve as any recommendation to buy or to sell.
Always make your analysis of your own before your trade.
If you find useful my analysis, please hit the LIKE button and follow me.